AI Pharma Solutions

AI Pharma Solutions, powered by Molecular Health's Dataome Technology, is a comprehensive AI-driven platform designed to transform drug development for pharmaceutical and biotech organisations. By merging world-class biomedical data, AI-powered analytics, and deep subject matter expertise, the platform delivers insights that go beyond human and experimental limitations — enabling reliable risk predictions, novel target discovery, and real-world evidence evaluation across the full drug development lifecycle.

Dataome Technology addresses the core challenge that the most valuable capabilities in drug development — anticipating risks, finding new targets, designing novel drugs, and evaluating real-world success — are inherently data-intensive and experimentally inaccessible. Molecular Health's platform eliminates these uncertainties by providing an interconnected, expert-curated knowledgebase interrogated through a unique portfolio of analytical technologies and AI methods.

Key Capabilities and Use Cases

• Understand the biology of complex diseases and identify better target-disease relationships
• Investigate molecular disease subtypes to identify and address responder patient populations
• Reveal new promising targets for the development of novel therapies
• Augment the value of pipeline drug candidates and portfolio drugs
• Optimize clinical trial structure, size, and relevant study cohorts
• Anticipate risks and mitigate failure of candidates at the clinical stage
• Conduct drug safety assessment using MH Effect technology

How Dataome Technology Generates New Knowledge

• Utilises proprietary text-mining to extract and integrate data from multiple global biomedical sources
• Assimilates and structures an unparalleled body of information into a highly interconnected knowledgebase
• Applies expert curation to ensure data quality throughout the knowledge-building process
• Interrogates the knowledgebase via a unique portfolio of analytical technologies and AI methods
• Intimately connects disparate data domains, extending the dimensions of analytical possibilities
• Every aspect of evidence capture and analysis is supervised by subject matter experts who understand which data and insights are essential to drug discovery, clinical development, and patient care

Where Dataome Technology Creates Value Across Drug Development

• Eliminates bottlenecks across the drug development pipeline
• Creates new opportunities to expand the uses of approved drugs or drug candidates
• Supports identification and qualification of targets and patient populations
• Enables prediction of safety risks before clinical failure
• Assists in prioritising indications for development
• Optimises clinical trial design to improve efficiency and reduce costs
• Facilitates evidence-based decisions at every stage of development

Molecular Health's team of subject matter experts works collaboratively with clients to address project-specific clinical and scientific questions, leveraging Dataome Technology to deliver tailored insights. The platform is available for demonstration and expert consultation, supporting organisations seeking to accelerate drug development, reduce costs, and improve the probability of clinical success.